The ENCIRCLE Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 786 participants.
Also called NCT04153292
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 786 participants
- Sponsor
- Registry
-
NCT04153292
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Australia, Canada, Israel, Netherlands, United Kingdom
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04153292. Non-randomized; no masking; primary purpose treatment. Start 2020-11-12 (actual); primary completion 2027-10-10 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The ENCIRCLE Trial
- Acronym
- ENCIRCLE
- Condition
- Mitral Regurgitation
- Condition
- Mitral Valve Insufficiency
- Intervention (Device)
- SAPIEN M3 valve and dock
- Lead sponsor
- Edwards Lifesciences
Record details
- Record id
cardio:ct-nct04153292- Content hash
b2f5fa71ea52ef5f45d0851bc7d4db4140ffbe7026474efa05174bfa46daea80